BTG1 and prostate carcinoma: Our data are in accordance with that of Chen et al. [25], who reported that BTG1 expression was higher in the prostate carcinoma cell line LNCaP than in the aggressively metastatic AI C4-2 cell line at both mRNA and protein level.